Expand LPTX Menu
LPTX MENU

LPTX Stock Summary and Trading Ideas (Leap Therapeutics | NASDAQ:LPTX)

Charts for Today's Stock Price and Implied Volatility in Leap Therapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for LPTX by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Leap Therapeutics (LPTX) Frequently Asked Questions

What does Leap Therapeutics do?

Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .

What symbol and exchange does Leap Therapeutics stock trade?

Leap Therapeutics trades on the NASDAQ stock market under the symbol LPTX.

What is Leap Therapeutics stock price doing today?

As of April 19, 2024, LPTX stock price declined to $2.80 with 199,161 million shares trading.

What is Leap Therapeutics's Beta?

LPTX has a beta of 3.95, meaning it tends to be more sensitive to market movements. LPTX has a correlation of 0.12 to the broad based SPY ETF.

How much is Leap Therapeutics worth?

LPTX has a market cap of $71.68 million. This is considered a Micro Cap stock.

What is the highest and lowest price Leap Therapeutics traded in the last 3 year period?

In the last 3 years, LPTX stock traded as high as $41.70 and as low as $1.24.

What are the top ETFs holding Leap Therapeutics?

The top ETF exchange traded funds that LPTX belongs to (by Net Assets): VTI, PINK, VXF, DFAT, AVSC.

Is Leap Therapeutics (LPTX) a good investment?

LPTX has underperformed the market in the last year with a return of -27.2%, while the SPY ETF gained +21.2%. In the last 3 month period, LPTX fell short of the market, returning -12.5%, while SPY returned +4.3%. However, in the most recent 2 weeks LPTX has outperformed the stock market by returning +11.6%, while SPY returned -3.5%.

What is the support and resistance for Leap Therapeutics (LPTX) stock price?

LPTX support price is $2.71 and resistance is $3.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LPTX stock will trade within this expected range on the day.